How does the CD42b antibody in mice reveal platelet function and its value in disease diagnosis and treatment?

ts play in physiological and pathological processes?

Platelets are not only key executors of hemostasis and thrombosis in the body but also important cells involved in multiple physiological and pathological processes such as immune regulation, inflammatory responses, angiogenesis, and tumor progression. During hemostasis, platelets rapidly respond to vascular injury through adhesion, aggregation, and release reactions to form the initial hemostatic plug. In inflammation and immune defense, platelets interact with leukocytes and endothelial cells, releasing various inflammatory mediators and growth factors to regulate the local immune microenvironment and influence wound healing. Additionally, platelets participate in tumor growth, metastasis, and the formation of tumor-associated thrombosis through multiple mechanisms. Therefore, precise monitoring of platelet function holds increasing value in clinical diagnosis, treatment evaluation, and prognosis assessment.

2. How do platelet membrane glycoproteins mediate their core functions?

Platelet function is mediated by the abundant membrane glycoproteins on their surface, which serve as the structural and functional basis for key events such as platelet activation, adhesion, and aggregation. Among these, the glycoprotein Ib-IX-V complex (comprising CD42a and CD42b subunits) is a critical receptor for platelet adhesion, particularly during the initial stages of vascular injury. It mediates the binding of platelets to von Willebrand factor (vWF) on the subendothelium, which is essential for maintaining platelet adhesion under high shear stress. The glycoprotein IIb/IIIa (integrin αIIbβ3) complex, also known as CD41/CD61, is the final common pathway for platelet aggregation. Upon activation, its conformation changes, enabling binding to ligands such as fibrinogen and mediating tight platelet-platelet aggregation. P-selectin (CD62P) is a specific marker of platelet activation, rapidly translocating from α-granule membranes to the plasma membrane upon activation. It mediates platelet-leukocyte adhesion and serves as a core molecule linking hemostasis, inflammation, and immunity.

3. What are the technical advantages of flow cytometry in detecting platelet membrane glycoprotein function?

Flow cytometry has become a core technology for platelet function detection, offering significant advantages in assessing membrane glycoprotein expression and activation. Its key features include: 1. Low sample requirements: It can directly use whole blood samples, requiring minimal volume, which greatly facilitates clinical sampling, especially for continuous monitoring in animal models such as mice. 2. High specificity and sensitivity: Fluorescently labeled monoclonal antibodies can precisely recognize and bind to specific platelet membrane glycoproteins (e.g., CD41, CD42b, CD62P) and distinguish between resting and activated states. 3. Multiparameter analysis: It enables simultaneous detection of multiple membrane glycoproteins in the same platelet sample, analyzing co-expression patterns of different functional markers to comprehensively evaluate platelet activation status and functional phenotypes. 4. Accurate quantification: It can precisely measure the percentage of positive platelets and the expression intensity (mean fluorescence intensity) of specific membrane glycoproteins, enabling quantitative analysis of functional states.

4. What are the specific clinical applications of platelet membrane glycoprotein function testing?

Flow cytometry-based detection of platelet membrane glycoproteins plays a pivotal role in the auxiliary diagnosis, efficacy monitoring, and personalized treatment of various diseases. Specific applications include:

1. Diagnosis and risk assessment of prothrombotic states and thrombotic diseases: Elevated expression of platelet activation markers (e.g., CD62P) indicates a hyperreactive platelet state, which is closely associated with the occurrence, progression, and risk of thrombotic diseases such as atherosclerosis, acute coronary syndrome, and deep vein thrombosis.

2. Diagnosis of congenital platelet function disorders: For example, Glanzmann thrombasthenia is characterized by significantly reduced or dysfunctional CD41/CD61 (glycoprotein IIb/IIIa), leading to impaired platelet aggregation. Bernard-Soulier syndrome is associated with defects in CD42a/CD42b (glycoprotein Ib-IX-V complex), resulting in impaired platelet adhesion.

3. Monitoring antiplatelet drug efficacy and guiding personalized therapy: For patients receiving antiplatelet drugs such as aspirin or clopidogrel, dynamic monitoring of platelet membrane glycoprotein expression (e.g., activated CD41/CD61, CD62P) can objectively assess drug inhibition effects. Effective treatment should lead to a significant and sustained reduction in activation marker levels. Persistent high levels may indicate drug resistance or suboptimal efficacy, necessitating treatment adjustments.

5. What is the instrumental value of mouse CD42b antibodies in research and disease models?

In mouse models, anti-mouse CD42b antibodies are indispensable tools for studying platelet biology and disease mechanisms. Their primary applications include: 1. Platelet identification and functional analysis: In flow cytometry, anti-CD42b antibodies are key markers for specifically identifying and gating mouse platelet populations, distinguishing them from other blood cells. Combined with other activation markers (e.g., CD62P), they can assess platelet activation status in inflammation, thrombosis, or tumor models. 2. Functional blockade studies: Using anti-CD42b antibodies for in vivo or in vitro blockade experiments can elucidate the role of glycoprotein Ib-IX-V complex-mediated adhesion in pathophysiological processes such as hemostasis, thrombosis, and inflammation, validating its potential as a therapeutic target. 3. Disease model construction and validation: In mouse models simulating Bernard-Soulier syndrome or studying thrombotic diseases, anti-CD42b antibodies can validate phenotypic features (e.g., platelet adhesion defects) or evaluate functional recovery post-intervention. Thus, high-quality mouse CD42b antibodies serve as a critical bridge between basic platelet biology research and preclinical translational medicine.

6. Which manufacturers provide mouse CD42b antibodies?

Hangzhou Start Biotech Co., Ltd. has independently developed the "PerCP-Cy5.5 Mouse Anti-Human CD42b Antibody (S-935-7)" (Catalog No.: S0B1729), a ready-to-use multicolor flow cytometry detection antibody with outstanding fluorescence performance, excellent specificity, and stability. This product uses high-purity mouse anti-human CD42b (GP1bα) monoclonal antibodies, optimized and labeled with PerCP-Cy5.5 fluorescent conjugate. It efficiently and specifically binds to human platelet surface CD42b molecules, enabling accurate platelet identification, counting, and functional state analysis in flow cytometry (FACS). It is a key tool for platelet research, thrombosis and bleeding disorder diagnosis, and drug evaluation.

Professional technical support: We provide detailed product instructions, including recommended sample handling (whole blood, platelet-rich plasma), staining conditions, and suggestions for multicolor panel combinations. Our technical team offers expert consultation on flow cytometry experimental design and optimization.

Hangzhou Start Biotech Co., Ltd. is committed to providing high-performance, high-quality flow cytometry antibodies for thrombosis and hemostasis research, hematological disease diagnosis, and drug development. For more details about the "PerCP-Cy5.5 Mouse Anti-Human CD42b Antibody" (Catalog No. S0B1729), technical specifications, or sample requests, please feel free to contact us.

Product Information

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.